Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Methotrexate and bone marrow metaphases.

J J Cunningham¹, A M Potter, A E Watmore

¹Centre for Human Genetics, Children's Hospital, Sheffield, England.

Cancer Genetics and Cytogenetics

|July 15, 1988

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumors.

The Dental register·2021

Same author

Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations.

Nature communications·2014

Same author

Modification of protein transfer across blood/cerebrospinal fluid barrier in response to altered plasma protein composition during development.

The European journal of neuroscience·2010

Same author

Postoperative spontaneous pneumoperitoneum.

American journal of surgery·2010

Same author

Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development.

The European journal of neuroscience·2007

Same author

Blood-CSF barrier function in the rat embryo.

The European journal of neuroscience·2006

Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010

Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010

Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010

Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010

Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010

Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010

See all related articles

Methotrexate (MTX) synchronization is ineffective for acute nonlymphocytic leukemia and myelodysplasia bone marrow cultures. This method did not improve mitotic index or metaphase quality in patient samples.

Area of Science:

Hematology
Cell Biology
Cancer Research

Background:

Cell cycle synchronization techniques are crucial for analyzing chromosomal abnormalities in hematological malignancies.
Methotrexate (MTX) block/thymidine release is a common method for synchronizing lymphocyte cultures.

Purpose of the Study:

To evaluate the efficacy of the MTX block/thymidine release synchronization technique in bone marrow cultures from patients with acute nonlymphocytic leukemia (ANLL) and myelodysplasia (MDS).
To assess the impact of preincubation and colcemid exposure duration on mitotic index (MI) and metaphase quality in these cultures.

Main Methods:

Bone marrow cultures were established from patients diagnosed with ANLL and MDS.
The MTX block/thymidine release synchronization protocol was applied to these cultures.

Related Experiment Videos

Mitotic index and metaphase quality were assessed, with additional experiments examining preincubation and colcemid exposure variables.

Main Results:

The MTX synchronization technique failed to improve the mitotic index or metaphase quality in ANLL and MDS bone marrow cultures.
This lack of improvement was observed in contrast to findings in stimulated lymphocyte cultures from normal individuals.
Unchanged division levels in the presence of MTX indicated the technique's unsuitability for synchronizing patient bone marrow cells.

Conclusions:

The MTX block/thymidine release synchronization method is not effective for bone marrow samples from ANLL and MDS patients.
Alternative synchronization strategies may be required for cytogenetic analysis in these specific hematological conditions.
Further research is needed to optimize cell synchronization for improved diagnostic accuracy in leukemia and myelodysplasia.